Both in Pharmaceuticals
Lexaria Bioscience vs Enveric Biosciences
Over the past year LEXX returned −78.8% and ENVB returned −81.6%; their daily moves had a correlation of 0.01.
LEXX −78.8% ENVB −81.6%Growth of $1, one year, split-adjusted
| Metric | LEXX | ENVB |
|---|---|---|
| Price | $3.13 | $1.45 |
| Market cap | $6.6M | $6.5M |
| Today | −2.95% | −1.36% |
| 1 month | −69.8% | +5.8% |
| 6 months | −73.2% | −19.0% |
| Year to date | −66.2% | −60.1% |
| 1 year | −80.1% | −80.1% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 34.0× | — |
| Net cash | $3.6M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 838.1% | 55.3% |
| Short % of float | 0.7% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).